Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
325,450
-
Share change
-
-114,323
-
Total reported value
-
$26,678,000
-
Price per share
-
$81.98
-
Number of holders
-
8
-
Value change
-
-$9,371,895
-
Number of sells
-
8
Institutional Holders of NOVOZYMES A S DKK 2.0 - COM as of Q4 2021
As of 31 Dec 2021,
NOVOZYMES A S DKK 2.0 - COM was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
325,450 shares.
The largest 8 holders included
SOMERVILLE KURT F, Hemenway Trust Co LLC, PUZO MICHAEL J, Broderick Brian C, Kidder Stephen W, Notis-McConarty Edward, Page Arthur B, and Dempze Nancy E.
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.